SG/CALL/CARL ZEISS MEDITEC/140/0.1/20.12.24 Share Price

Warrant

DE000SV9VW92

Market Closed - Deutsche Boerse AG 20:49:35 04/07/2024 BST
0.014 EUR 0.00% Intraday chart for SG/CALL/CARL ZEISS MEDITEC/140/0.1/20.12.24
Current month-6.67%
1 month-44.00%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
04/07/24 0.014 0.00%
03/07/24 0.014 0.00%
02/07/24 0.014 +7.69%
01/07/24 0.013 -13.33%
28/06/24 0.015 0.00%

Delayed Quote Deutsche Boerse AG

Last update July 04, 2024 at 08:49 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying CARL ZEISS MEDITEC AG
IssuerLogo Issuer Société Générale Société Générale
WKN SV9VW9
ISINDE000SV9VW92
Date issued 19/07/2023
Strike 140
Maturity 20/12/2024 (169 Days)
Parity 10 : 1
Emission price 0.75
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.94
Lowest since issue 0.005

Company Profile

Carl Zeiss Meditec AG is a Germany-based medical technology and device company. It offers offers complete solutions to diagnose and treat ophtalmic diseases, visualization solutions for microsurgery and other technologies, such as intraoperative radiotherapy. The Company operates in two segments: Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment comprises activities in the area of ophthalmology, such as intraocular lenses, surgical visualization solutions and medical laser and diagnostic systems. The Microsurgery segment includes activities of neuro, ear, nose and throat surgery, as well as the activities in the field of intraoperative radiation. The Company has various production sites in Europe, the United States and Asia.
Sector
-
More about the company

Ratings for Carl Zeiss Meditec AG

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: Carl Zeiss Meditec AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
15
Last Close Price
65.3 EUR
Average target price
79.73 EUR
Spread / Average Target
+22.10%
Consensus